Cleared Traditional

K910733 - MEDISYSTEMS ANTI-STICK INJECTION SITE NEEDLE

K910733 is an FDA 510(k) clearance for MEDISYSTEMS ANTI-STICK INJECTION SITE N..., manufactured by Medisystems Corp.. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 105-day FDA review.

K910733 · Medisystems Corp. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
105d
Days
Class 2
Risk

K910733 is an FDA 510(k) clearance for the MEDISYSTEMS ANTI-STICK INJECTION SITE NEEDLE. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Medisystems Corp. (San Francisco, US). The FDA issued a Cleared decision on June 6, 1991 after a review of 105 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Medisystems Corp. devices

FDA 510(k) Submission Details - K910733

510(k) Number K910733 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 21, 1991
Decision Date June 06, 1991
Days to Decision 105 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d faster than avg
Panel avg: 129d · This submission: 105d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 466
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K910733.
CHEMO-PORT
K913386 · Hdc Corp. · Jan 1992
MX927 BLOOD TRANSFER DEVICE
K913498 · Medex, Inc. · Nov 1991
MEGA MYELOGRAM KIT
K913141 · Megadyne Medical Products, Inc. · Oct 1991
SAFETY NEEDLE SHEATH, MODIFICATION
K911037 · Concord/Portex · May 1991
VIAL ACCESS CANNULA
K905664 · Baxter Healthcare Corp · Mar 1991
SAFETY NEEDLE SHEATH
K904198 · Concord/Portex · Dec 1990